Loading people...
Don Milder is the Co-Founder and Managing Partner at Versant Ventures, a healthcare investment firm based in San Francisco, California. Since co-founding the firm in 1999, he has helped scale its operations to manage over $4 billion in assets. Prior to establishing Versant, he served as a Partner leading healthcare investments at CrossPoint Venture Partners and held executive roles as the Chief Executive Officer of Infusion Systems Corp. and President of TRIMED Corp. Throughout his career, he has directed capital into early-stage medical device startups, holding board positions at companies including Inari Medical, Glaukos, and Okami Medical. He holds a bachelor's degree from Union College and a Master of Business Administration from Harvard Business School. His current focus remains on advancing early-stage life sciences and medical technology enterprises from initial discovery through public offerings.
Don Milder is a highly respected figure in the venture capital landscape, currently serving as the Managing Partner at Versant Ventures. Versant Ventures is renowned as a leading healthcare venture capital firm dedicated to investing in innovative biotechnology, pharmaceutical, and medical technology companies. In his capacity as Managing Partner, Don Milder plays a crucial role in the firm's overall success, overseeing vital operational, financial, and investor relations activities. His leadership ensures the smooth functioning of the firm, enabling its investment teams to focus on identifying and nurturing the next generation of life science breakthroughs.
Milder's responsibilities extend to managing the firm's financial health, optimizing operational efficiencies, and fostering strong relationships with limited partners. He is instrumental in shaping Versant's fund strategy and ensuring the firm's long-term growth and stability. While Versant Ventures primarily focuses on early-stage investments in novel therapeutics, medical devices, and other life science innovations, Don's strategic oversight supports the entire portfolio, from initial investment to successful exit.
Before joining Versant Ventures, Don Milder built a robust career in the healthcare investment sector. He previously held a significant position as a Partner at Sprout Group, another well-regarded healthcare venture capital firm. His experience at Sprout Group provided him with deep insights into the intricacies of venture capital operations and portfolio management within the life sciences. Prior to his venture capital roles, Milder also gained valuable experience at BT Alex. Brown, further solidifying his financial acumen and understanding of the broader investment landscape. This comprehensive background in finance and healthcare investment operations has equipped him with the unique skills necessary to manage the complex demands of a top-tier venture capital firm like Versant.
Under Don Milder's operational leadership, Versant Ventures has continued to build an impressive portfolio of companies that are making significant advancements in healthcare. While his role is more focused on the strategic and operational backbone of the firm rather than leading individual deal investments, his contributions are fundamental to the success of Versant's notable investments across various therapeutic areas and technological platforms. His expertise ensures that the firm has the resources and infrastructure to support its portfolio companies effectively, driving their growth and ultimately delivering value to patients and investors alike. Don Milder's strategic vision and operational excellence are key drivers behind Versant Ventures' continued prominence in the competitive healthcare venture capital market.
Don Milder is the Managing Partner at Versant Ventures, a leading healthcare venture capital firm. He is responsible for overseeing the firm's operations, finance, and investor relations.
As Managing Partner at Versant Ventures, Don Milder's role is primarily operational and strategic, supporting the firm's investments in early-stage biotechnology, pharmaceutical, and medical technology companies. Versant focuses on novel therapeutics, medical devices, and other life science innovations.
Don Milder works at Versant Ventures, a prominent healthcare venture capital firm.
